IFP Advisors Inc decreased its stake in shares of Chemed Co. (NYSE:CHE – Free Report) by 34.0% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 485 shares of the company’s stock after selling 250 shares during the quarter. IFP Advisors Inc’s holdings in Chemed were worth $260,000 at the end of the most recent quarter.
Several other institutional investors have also recently made changes to their positions in the stock. FMR LLC boosted its stake in shares of Chemed by 23.8% during the 3rd quarter. FMR LLC now owns 238,616 shares of the company’s stock worth $143,401,000 after acquiring an additional 45,917 shares during the period. Principal Financial Group Inc. increased its holdings in shares of Chemed by 114.1% during the 4th quarter. Principal Financial Group Inc. now owns 74,658 shares of the company’s stock worth $39,554,000 after acquiring an additional 39,791 shares during the last quarter. Thrivent Financial for Lutherans increased its holdings in shares of Chemed by 25.3% during the 3rd quarter. Thrivent Financial for Lutherans now owns 146,017 shares of the company’s stock worth $87,752,000 after acquiring an additional 29,445 shares during the last quarter. Aureus Asset Management LLC increased its holdings in shares of Chemed by 3,147.2% during the 3rd quarter. Aureus Asset Management LLC now owns 29,939 shares of the company’s stock worth $17,993,000 after acquiring an additional 29,017 shares during the last quarter. Finally, Boston Trust Walden Corp increased its holdings in shares of Chemed by 10.0% during the 4th quarter. Boston Trust Walden Corp now owns 242,172 shares of the company’s stock worth $128,303,000 after acquiring an additional 22,105 shares during the last quarter. Institutional investors and hedge funds own 95.85% of the company’s stock.
Analysts Set New Price Targets
A number of research analysts recently weighed in on the company. StockNews.com lowered Chemed from a “buy” rating to a “hold” rating in a report on Thursday. Royal Bank of Canada decreased their price objective on Chemed from $697.00 to $633.00 and set an “outperform” rating on the stock in a report on Tuesday, November 5th.
Insider Buying and Selling at Chemed
In other news, VP Brian C. Judkins acquired 145 shares of the firm’s stock in a transaction on Monday, December 30th. The shares were purchased at an average cost of $519.50 per share, with a total value of $75,327.50. Following the acquisition, the vice president now directly owns 1,678 shares in the company, valued at $871,721. This represents a 9.46 % increase in their position. The purchase was disclosed in a document filed with the SEC, which is accessible through this link. Insiders own 3.32% of the company’s stock.
Chemed Price Performance
Shares of NYSE CHE opened at $600.46 on Monday. The stock’s fifty day moving average price is $546.69 and its two-hundred day moving average price is $563.39. Chemed Co. has a one year low of $512.12 and a one year high of $654.62. The firm has a market cap of $9.04 billion, a price-to-earnings ratio of 30.34, a P/E/G ratio of 2.15 and a beta of 0.48.
Chemed Dividend Announcement
The company also recently disclosed a quarterly dividend, which will be paid on Friday, March 14th. Shareholders of record on Monday, February 24th will be issued a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a yield of 0.33%. The ex-dividend date is Monday, February 24th. Chemed’s dividend payout ratio is 10.05%.
Chemed Profile
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.
See Also
- Five stocks we like better than Chemed
- What is the Nikkei 225 index?
- Chaos and Cash: Finding Opportunity in Volatility
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- Realty Income: An Anchor in Volatile Markets
- How Can Investors Benefit From After-Hours Trading
- Autodesk Designs Value for Investors: Uptrend Set to Continue
Want to see what other hedge funds are holding CHE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Chemed Co. (NYSE:CHE – Free Report).
Receive News & Ratings for Chemed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed and related companies with MarketBeat.com's FREE daily email newsletter.